Life Sciences Greenhouse Investments — 2023 Investments
3 investments dated 2023 · listed companies and verified rows first · show all
Unable to determine company information; page contains only placeholder Lorem ipsum text.
AI & Machine LearningDigital HealthHealthtechPittsburgh, US
Gilan El Saadawi(Executive Officer, Director, Promoter)Betsy Castillo(Head of Clinical Data Abstraction)inMichael Finke(Director)Brenton Burns(Director)Scot Stevens(Director)Aaron Brauser(Executive Officer, Director, Promoter)
Co-investorsAsset Management CompanyCU Healthcare Innovation FundFrist Cressey VenturesHealthy VenturesKatalyst VenturesKatalyst.Ventures+10 more
Ilico Genetics develops a blood-based molecular test for the early detection of gastric cancer using methylated DNA markers, designed to identify disease years before traditional methods.
BiotechHealthtechMedical DevicesSantiago, CL
Alejandro Corvalán(MD)inFernando Alarcon(MBA)inMaria Jose Maturana Rojas(Director)Alejandro Hernan Corvalan Rodriguez(Director)Fernando A Alarcon Hardy(Executive Officer, Director)
OK2StandUP develops smart activity monitoring systems with AI-based alerts for healthcare organizations to prevent falls and support caregiver awareness in patient care settings.
AI & Machine LearningHealthtechMedical DevicesPittsburgh, US
Eunice Yang, PhD(Founder and CEO)Eunice E. Yang(Executive Officer, Director)
Co-investorsScaleGood Fund LP (powered by TELUS)Beta Boom
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.










